Sign in Register

Drug class

Beta-Adrenergic Agents Long- and Short-Acting (Inhaled)

The classification "Beta-Adrenergic Agents Long- and Short-Acting (Inhaled)" functions primarily as a formulary and administrative grouping that encompasses both short-acting (SABA) and long-acting (LABA) inhaled beta-2 adrenergic receptor agonists. Read more about Beta-Adrenergic Agents Long- and Short-Acting (Inhaled)

137 drugs in this class 58 manufacturers

Advertisement

Related classes & indications

Iron Chelating AgentsOther therapeutic classes · 45 prescription drugs Phosphodiesterase-4 (PDE4) inhibitorsOther therapeutic classes · 20 prescription drugs Maintenance Therapy For AsthmaTop indication · 168 prescription drugs

Drugs in Beta-Adrenergic Agents Long- and Short-Acting (Inhaled)

Showing 37–45 of 137 drugs

Filter & compare in the drug finder → Opens the drug finder with Beta-Adrenergic Agents Long- and Short-Acting (Inhaled) preselected. Add indication or manufacturer filters there.

About Beta-Adrenergic Agents Long- and Short-Acting (Inhaled).

The classification "Beta-Adrenergic Agents Long- and Short-Acting (Inhaled)" functions primarily as a formulary and administrative grouping that encompasses both short-acting (SABA) and long-acting (LABA) inhaled beta-2 adrenergic receptor agonists.

These bronchodilator agents stimulate beta-2 adrenergic receptors in airway smooth muscle to increase intracellular cyclic AMP, resulting in muscle relaxation and widened airways.

Clinically, short-acting formulations provide rapid relief for acute bronchospasm, while long-acting agents deliver extended airway maintenance.

Together, they represent standard therapies used primarily in the management and prevention of airflow limitation in asthma and chronic obstructive pulmonary disease (COPD).